Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use

US Patent 10233178 · Granted Mar 19, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alpha, beta unsaturated methacrylic esters with anti-inflammatory properties2025
Itaconic acid derivatives and uses thereof intreating an inflammatory disease or2025
Methods to determine KDM1A target engagement and chemoprobes useful therefor2025
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2024
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine2024
Isoquinoline compounds, methods for their preparation, and therapeutic uses ther2022
Methods to determine KDM1A target engagement and chemoprobes useful therefor2021
Combinations of LSD1 inhibitors for the treatment of hematological malignancies2021
Kinase inhibitors2021
Kinase inhibitors2021
4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,2020
4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,2020